Inspire Investing’s Cellebrite CLBT Stock Holding History

Inspire Investing’s Portfolio CLBT Stock Details CLBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-77,791	Closed	-$862K	–	808
2024 Q1	$862K	Buy	+77,791	New	+$794K	0.09%	261

Other funds holding CLBT

TWCM

True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return

Crosslink Capital Menlo Park, California $1.35B AUM 35.86% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return

GRIM

Greenhaven Road Investment Management Greenwich, Connecticut $154M AUM 15.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Inspire Investing's CLBT Position: Q2 2024 in Review

Inspire Investing sold out of Cellebrite (CLBT) in Q2 2024, closing a stake of 77,791 shares — an estimated $862K sold.

Inspire Investing first reported a position in CLBT in Q1 2024 and held it in 1 quarter. The position peaked at $862K in Q1 2024. 148 funds tracked by Wall St. Rank hold CLBT as of Q2 2024.

Inspire Investing reported no remaining Cellebrite position as of Q2 2024 after selling out during the quarter.
Inspire Investing sold 77,791 Cellebrite shares in Q2 2024, an estimated $862K.
Inspire Investing first reported a position in Cellebrite in Q1 2024 and held it in 1 quarter.
Inspire Investing's Cellebrite position peaked at $862K in Q1 2024.
148 funds tracked by Wall St. Rank held Cellebrite as of Q2 2024.

Based on Inspire Investing's 13F filing for Q2 2024, filed 12 Aug 2024.